BOSTON, October 7, 2026 – Jnana Therapeutics announces that its research collaborator Roche has initiated a Phase 1 clinical trial and has dosed the first participant with a small molecule discovered through their research efforts. Jnana, an Otsuka Group Company, is a clinically validated biotech leveraging its proprietary RAPID chemoproteomics platform to find small… The post Jnana Therapeutics Announces Clinical Milestone Achieved Under First Collaboration with Roche appeared first on Jnana Therapeutics .
Discovery
Learnings
- auto_storiesStories
- categoryAreas
- helpFAQ
- forumConversations
- descriptionPapers
- mailNewsletters
- video_libraryVideos
- timelineTimeline
Guidance
- codeTechnology of APIs
- business_centerBusiness of APIs
- campaignEvangelism of APIs
- gavelGovernance of APIs
- historyHistory of APIs
- account_balancePolitics of APIs
Toolbox
- domainProviders
- apiAPIs
- cloudSolutions
- buildTools
- verifiedStandards
- gavelRegulations
- horizontal_ruleHeaders
- layersOverlays
- extensionExtensions
- schemaSchema
- policyPolicies
- ruleRules